Valeritas is a commercial stage medical technology company focused on developing innovative technologies to improve the health and quality of life of people with Type diabetes. Valeritas flagship product, V Go Disposable Insulin Delivery device, is a simple, wearable, basal bolus insulin delivery solution for patients with Type diabetes that enables patients to administer a continuous preset basal rate of insulin over hours. It also provides on demand bolus dosing at mealtimes. It is the only basal bolus insulin delivery device on the market today specifically designed keeping in mind the needs of type diabetes patients. Headquartered in Bridgewater, New Jersey, Valeritas operates its R amp D functions in a state of the art facility in Shrewsbury, Massachusetts. For more information, please visit www.valeritas.com.
Quote | Valeritas Holdings (NASDAQ:VLRX)
Last: | $ |
---|---|
Change Percent: | 24.97% |
Open: | $0.336 |
Close: | $0.4139 |
High: | $0.512 |
Low: | $0.311 |
Volume: | 3,244,478 |
Last Trade Date Time: | 02/12/2020 04:25:57 pm |
News | Valeritas Holdings (NASDAQ:VLRX)
BRIDGEWATER, N.J. , Feb. 9, 2020 /PRNewswire/ -- Valeritas Holdings, Inc. (NASDAQ: VLRX) ("Valeritas" or the "Company"), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device , today announced an agreement to sell substantially all of the business to Z...
Gainers: Marinus Pharmaceuticals (NASDAQ: MRNS ) +42% . More news on: Marinus Pharmaceuticals, Inc., Prothena Corporation plc, Applied Genetic Technologies Corporation, Stocks on the move, Read more ...
Message Board Posts | Valeritas Holdings (NASDAQ:VLRX)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Valeritas Holdings Company Name:
VLRX Stock Symbol:
NASDAQ Market:
BRIDGEWATER, N.J. , Feb. 9, 2020 /PRNewswire/ -- Valeritas Holdings, Inc. (NASDAQ: VLRX) ("Valeritas" or the "Company"), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device , today announced an agreement to sell substantially all of the business to Z...
BRIDGEWATER, N.J., Dec. 20, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , today announced revised revenue guida...
BRIDGEWATER, N.J., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced positive data from its pr...